Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin79.6%76.3%68.7%
Operating margin-157.7%-193.1%-300.4%
Net margin-186.2%-257.9%-318.4%
EBITDA margin-145.4%-181.8%-291.3%
Returns
Return on assets-70.5%+227pp-65.8%+1,020pp-36.7%-527.5%-297.8%
Efficiency
Asset turnover0.4×0.3×0.1×
Liquidity
Current ratio2.8×+2.6×2.1×+1.7×+1.4×0.1×-0.8×0.2×-1.2×
Quick ratio1.9×+1.7×1.1×+0.8×+0.4×0.1×-0.8×0.2×-1.2×
Cash ratio1.3×+1.3×0.7×+0.6×0.6×+0.2×-0.9×-1.3×
Leverage
Debt-to-equity0.8×0.1×
Debt-to-assets0.2×
Interest coverage-8.4×-10.8×-12.3×-17.9×
Per Share
Book value per share$10.60+255%$20.68+525%-$6.85
Valuation
Market capitalization$98.22M+92.4%$95.69M$85.9M
Enterprise value$95.89M$81.1M$74.55M
Price / sales3.6×5.7×11.6×
Price / book2.8×2.5×1.5×
EV / sales3.5×4.8×10.1×
Earnings yield-52.5%-45.3%-27.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pelthos Therapeutics Inc.'s profit margins?
Pelthos Therapeutics Inc. (PTHS) runs a 79.6% gross margin and a -157.7% operating margin, with a -186.2% net margin.
Where do Pelthos Therapeutics Inc.'s ratios come from?
Every ratio is computed from Pelthos Therapeutics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.